Open the Narrowit.com mutual fund research report for FSPHX dated 2026-06-12, including valuation, performance, risk factors, entry strategy, and scorecard analysis.

Open the Narrowit.com mutual fund research report for FSPHX dated 2026-06-12, including valuation, performance, risk factors, entry strategy, and scorecard analysis.

Open the Narrowit.com mutual fund research report for FSPHX dated 2026-06-27, including valuation, performance, risk factors, entry strategy, and scorecard analysis.

Open the Narrowit.com mutual fund research report for FSPHX dated 2026-06-12, including valuation, performance, risk factors, entry strategy, and scorecard analysis.

Open the Narrowit.com mutual fund research report for FSPHX dated 2026-06-12, including valuation, performance, risk factors, entry strategy, and scorecard analysis.

After lagging the S&P 500 Index in each of the past three calendar years, health care stocks have outperformed the benchmark handily since the start of 2025, albeit with a slim loss. The S&P 500 has declined 14% for the year to date through April 7; health care stocks have lost just 2%. Our favorite health fund, the Fidelity Select Health Care Portfolio (FSPHX) – a member of the Kiplinger 25, the best no-load mutual funds – lags the sector index for the year to date. But over the past 12 months, the fund outpaced 65% of its peers despite a 6.9% loss.